Novacyt S.A. (“Novacyt”, the “Company” or the “Group”) Full Year Trading update Integration of Yourgene Health plc ahead of schedule Paris, France, and Eastleigh and Manchester, UK – 25 January 2024 – Novacyt S.A....

Novacyt S.A. (“Novacyt”, the “Company” or the “Group”) Appointment of CFO Paris, France, and Eastleigh and Manchester, UK – 2 January – Novacyt S.A. (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international molecular diagnostics...

Paris, France, Eastleigh and Manchester, UK – 21 December 2023 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international molecular diagnostics company with a broad portfolio of integrated technologies and...

Paris, France, and Eastleigh UK – 26 October 2023 – Novacyt S.A. (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces that all resolutions proposed at the...

Paris, France, and Eastleigh UK – 11 October 2023 – Novacyt S.A. (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces that shareholders are now able to...

AGM to be held in Paris on Thursday 26 October Paris, France and Eastleigh, UK – 05 October 2023 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics,...

Paris, France and Eastleigh, UK – 28 September 2023 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, will be holding its annual general meeting (AGM) exclusively...